2026. Comprehensive in-Silico Characterization of Deleterious IDH2 Variants and Their Structural and Functional Implications in Acute Myeloid Leukemia: In-Silico for Deleterious IDH2 Variants and Functional Implications in AML. Futuristic Biotechnology. 6, 2 (Jun. 2026), 25–32. DOI:https://doi.org/10.54393/fbt.v6i2.238.